triazoles has been researched along with Leiomyomatosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Kusunoki, S; Matsuoka, S; Ogishima, D; Ota, T; Sugimori, Y | 1 |
| Kamiura, S; Masuhara, K; Takeda, T | 1 |
| Makedos, GA; Papanicolaou, AN; Varelas, FK; Vavatsi-Christaki, N; Vlassis, GD | 1 |
| Biri, A; Guner, H; Korucuoglu, U; Tiras, B; Zumrutbas, N | 1 |
1 trial(s) available for triazoles and Leiomyomatosis
| Article | Year |
|---|---|
The effect of anastrazole on symptomatic uterine leiomyomata.
Topics: Adult; Age Factors; Anastrozole; Antineoplastic Agents, Hormonal; Endometrium; Estradiol; Female; Gonadotropins; Hematocrit; Humans; Leiomyomatosis; Middle Aged; Nitriles; Organ Size; Prospective Studies; Severity of Illness Index; Treatment Outcome; Triazoles; Uterine Neoplasms | 2007 |
3 other study(ies) available for triazoles and Leiomyomatosis
| Article | Year |
|---|---|
Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata.
Topics: Adult; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Neoplasm Recurrence, Local; Nitriles; Pelvic Neoplasms; Peritoneal Cavity; Triazoles | 2017 |
Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.
Topics: Aged; Anastrozole; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Nitriles; Peritoneal Cavity; Postmenopause; Triazoles | 2008 |
Intravenous leiomyomatosis treated with aromatase inhibitor therapy.
Topics: Adult; Angiography; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Nitriles; Treatment Outcome; Triazoles; Uterine Neoplasms | 2008 |